Similar Articles
1311 Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma
1312 Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma
1313 Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study
1314 Axl glycosylation mediates tumor cell proliferation, invasion and lymphatic metastasis in murine hepatocellular carcinoma
1315 Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
1316 Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study
1317 High-risk esophageal varices in patients treated with locoregional therapy for hepatocellular carcinoma: Assessment with liver computed tomography
1318 Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma
1319 Prognosis of hepatocellular carcinoma expressing cytokeratin 19: Comparison with other liver cancers
1320 Hyperthermia inhibits hypoxia-induced epithelial-mesenchymal transition in HepG2 hepatocellular carcinoma cells
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA